Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options — a COG and Target Pediatric AML Study

Jenny L. Smith, MSc, MD, Rhonda E. Ries, MA, Marianne T. Santaguida, BSc, PhD, Christos Gekas, PhD, Todd A Alonzo, PhD, Robert B Gerbing, MA, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Tiffany Hylkema, BS, Lisa Eidenschink Brodersen, PhD, Michael R. Loken, PhD, Hamid Bolouri, PhD, Soheil Meshinchi, MD PhD

Blood (2018) 132 (Supplement 1): 881.

https://doi.org/10.1182/blood-2018-99-115544

Published: 2018

Journal Articles

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Juan Manuel Alonso Dominguez, MD PhD MSc, Alicia Arenas, PhD, Pilar Llamas, MDPhD, Diego Velasco, Aránzazu García-Raso, PhD, Jose Luis Lopez Lorenzo, MD, Mireia Atance, Rocio N Salgado, PhD, Joaquin Martinez Lopez, MD PhD

Blood (2017) 130 (Supplement 1): 5245.

https://doi.org/10.1182/blood.V130.Suppl_1.5245.5245

Published: 2017

Journal Articles

Phase 2 Trial of Smoothened (SMO) Inhibitor PF-04449913 (PF-04) in Refractory Myelodysplastic Syndromes (MDS)

Jeffrey E. Lancet, MD, Rami S Komrokji, MD, Kendra L. Sweet, MD, Vu H. Duong, MD, Kathy L McGraw, PhD, Ling Zhang, MD, Lisa Ann Nardelli, BS, Zhenjun Ma, PhD, Richard R Reich, PhD, Eric Padron, MD, Alan F List, MD

Blood (2016) 128 (22): 3174.

https://doi.org/10.1182/blood.V128.22.3174.3174

Published: 2016

Journal Articles

BM-MSC Hhip Induced Microenvironment Protection from Chemotherapy in AML Via Ptch/Smo/Gli Pathwa

Xuejie Jiang, Dan Xu, Fang Chen, Ling Jiang, Guopan Yu, Fanyi Meng, Xiaoli Liu, PhD, Qifa Liu, MD

Blood (2016) 128 (22): 5235.

https://doi.org/10.1182/blood.V128.22.5235.5235

Published: 2016

Journal Articles

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

Juan Manuel Alonso-Dominguez, MD, Felipe Casado, MariaTeresa Gómez Casares, MDPhD, Ismael Buno, Francisca Ferrer-Marin, Eduardo Anguita, MD PhD, Alicia Arenas, Rafael Del Orbe, MD, Rosa M. Ayala, MD PhD, Pilar Llamas, MD, Pedro Sanchez-Godoy, MD, Carmen Burgaleta, MD, Valentín García-Gutierrez, Juan Luis Steegmann, MD PhD, Joaquin Martinez-Lopez

Blood (2015) 126 (23): 2791.

https://doi.org/10.1182/blood.V126.23.2791.2791

Published: 2015

Journal Articles

Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo

Lukasz P Gondek, MD PhD, Yiting Lim, PhD, Hideki Makishima, MD PhD, Qiuju Wang, MA, Jaroslaw P. Maciejewski, MD PhD FACP, Peter D Aplan, MD, Amy E. DeZern, MD MHS, William Matsui, MD

Blood (2014) 124 (21): 528.

https://doi.org/10.1182/blood.V124.21.528.528

Published: 2014

Journal Articles

To Gli or not to Gli

Lawrence H. Boise

Blood (2014) 124 (13): 2008–2009.

https://doi.org/10.1182/blood-2014-08-592311

Published: 2014

Journal Articles

PTCH1 Expression At Diagnosis Reliably Predicts Treatment Failure in Imatinib-Treated Chronic Myeloid Leukaemia Patients

Juan M. Alonso-Dominguez, Sr., MD, Jacob Grinfeld, MD, Mary Alikian, David Marin, Alistair Reid, PhD, Mustafa Daghistani, Jane Apperley, John M Goldman, MD, Corinne Hedgley, Steve O‘Brien, Richard E. Clark, MD, Letizia Foroni, Gareth Gerrard, PhD

Blood (2012) 120 (21): 875.

https://doi.org/10.1182/blood.V120.21.875.875

Published: 2012

Journal Articles

Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL

Sarah Decker, Katja Zirlik, Lauritte Djebatchie, David Hartmann, Gabriele Ihorst, Annette Schmitt-Graeff, Dieter Herchenbach, Hassan Jumaa, Markus Warmuth, Hendrik Veelken, Christine Dierks

Blood (2012) 119 (4): 997–1007.

https://doi.org/10.1182/blood-2011-06-359075

Published: 2012

Includes: Supplemental data

Journal Articles

A Novel Look at MDS Patients: Utilization and Effectiveness of a SNP Microarray for the Detection of Both Copy Number and Copy Neutral Changes

Inder K. Gadi, PhD, Peter Papenhausen, PhD, Stuart Schwartz, PhD, FACMG, James Tepperberg, PhD, FACMG

Blood (2010) 116 (21): 4846.

https://doi.org/10.1182/blood.V116.21.4846.4846

Published: 2010

Journal Articles

Hedgehog regulates distinct vascular patterning events through VEGF-dependent and -independent mechanisms

Leigh Coultas, Erica Nieuwenhuis, Gregory A. Anderson, Jorge Cabezas, Andras Nagy, R. Mark Henkelman, Chi-Chung Hui, Janet Rossant

Blood (2010) 116 (4): 653–660.

https://doi.org/10.1182/blood-2009-12-256644

Published: 2010

Includes: Supplemental data

Journal Articles

The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms

Sarah L. Siggins, Nhu-Y N. Nguyen, Matthew P. McCormack, Sumitha Vasudevan, Rehan Villani, Stephen M. Jane, Brandon J. Wainwright, David J. Curtis

Blood (2009) 114 (5): 995–1004.

https://doi.org/10.1182/blood-2009-03-208330

Published: 2009

Includes: Supplemental data

Journal Articles

Ptch1 Regulates the Bone Marrow Cell Niche Critical for Survival of Pre-B Cells but Not Hematopoietic Stem Cells

David J. Curtis, MD, PhD, Sarah Siggins, PhD, Nhu-Y Nguyen, BSc, Rehan Hetherington, BSc, Brandon Wainwright, PhD

Blood (2008) 112 (11): 3571.

https://doi.org/10.1182/blood.V112.11.3571.3571

Published: 2008

Journal Articles

Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.

Qiuju Wang, MS, Craig Peacock, PhD, Kortney Hensley, Sarah Brennan, Akil Merchant, MD, Evan Jones, Irwin Freed, Richard Ambinder, MD, Karen McGovern, Martin Tremblay, D. Neil Watkins, MD, PhD, William Matsui, MD

Blood (2007) 110 (11): 3582.

https://doi.org/10.1182/blood.V110.11.3582.3582

Published: 2007

Journal Articles

The Hedgehog receptor Patched controls lymphoid lineage commitment

Anja Uhmann, Kai Dittmann, Frauke Nitzki, Ralf Dressel, Milena Koleva, Anke Frommhold, Arne Zibat, Claudia Binder, Ibrahim Adham, Mirko Nitsche, Tanja Heller, Victor Armstrong, Walter Schulz-Schaeffer, Jürgen Wienands, Heidi Hahn

Blood (2007) 110 (6): 1814–1823.

https://doi.org/10.1182/blood-2007-02-075648

Published: 2007

NARROW

Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options — a COG and Target Pediatric AML Study

Characterization of Ex-Vivo PTCH1 Expression Under Tyrosine Kinase Inhibitors Treatment and Determination of Downstream Effectors Oh Hedgehog Pathway in CML

Phase 2 Trial of Smoothened (SMO) Inhibitor PF-04449913 (PF-04) in Refractory Myelodysplastic Syndromes (MDS)

BM-MSC Hhip Induced Microenvironment Protection from Chemotherapy in AML Via Ptch/Smo/Gli Pathwa

Measurement of PTCH1 Expression at Diagnosis Is an Appropriate Tool for Tyrosine Kinase Inhibitors Selection in Chronic Myeloid Leukemia Patients in Chronic Phase

Aberrant Hedgehog Pathway Activity Marks Clinical MDS Progression and Accelerates Leukemic Transformation in Vivo

To Gli or not to Gli

PTCH1 Expression At Diagnosis Reliably Predicts Treatment Failure in Imatinib-Treated Chronic Myeloid Leukaemia Patients

Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL

A Novel Look at MDS Patients: Utilization and Effectiveness of a SNP Microarray for the Detection of Both Copy Number and Copy Neutral Changes

Hedgehog regulates distinct vascular patterning events through VEGF-dependent and -independent mechanisms

The Hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms

Ptch1 Regulates the Bone Marrow Cell Niche Critical for Survival of Pre-B Cells but Not Hematopoietic Stem Cells

Aberrant Hedgehog Signaling Represents a Novel Therapeutic Target in B Cell Lymphomas.

The Hedgehog receptor Patched controls lymphoid lineage commitment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only